InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,319.20
(
2.45%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.15
(
-0.24%
)
Bitcoin
63,310.63
(
0.57%
)
Post# of 6306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BioBull1

Send PM Follow Ignore
Followers 0
Posts 56
Boards Moderated 0
Alias Born 01/11/2016

BioBull1

Re: TheHound post# 5654

Monday, 11/28/2016 7:56:52 PM

Monday, November 28, 2016 7:56:52 PM

Post# of 6306
Hound, you just agreed with me last week.

I am stating the INSPIRE trial could require another 21 patients if the CEO has not been communicating openly to shareholders.

Again, from the 10Q

Quote:
"After review of the six-month pilot data package, the FDA approved The INSPIRE study to expand enrollment from 12 to up to 30 patients."


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up